Answers are grounded in this paper and cite their sources.
Large-scale analysis reveals unique toxicity profiles of immune checkpoint inhibitors in older adults, suggesting age-specific monitoring needs.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Awidi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: